NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM5718992 Query DataSets for GSM5718992
Status Public on Jul 18, 2024
Title 06__T15smarcb1A3
Sample type SRA
 
Source name T15 cell line
Organism Mus musculus
Characteristics cell line: T15
treatment group: Smarcb1-reexpression
Treatment protocol For T15-Smarcb1 re-expression, T15 cells were lentivirally transduced with a control (Smarcb1-) or Smarcb1 expression plasmid pInd20. After antibiotic selection (G418) and Doxycyclin induction (0.5 µg/µl) (72 h) total RNA was extracted and sequenced. For T15-SAHA: T15 cells were treated with SAHA (1 µM final concentration) or vehicle twice in 72 h. Afterwards, RNA was isolated and sequenced.
Growth protocol All cells were maintained at 37°C and 5% CO2 in RPMI 1640 medium with 10% FBS, 1% HEPES 1M, 1% penicillin/streptomycin (10,000 U/ml), sodium pyruvate (100 nM), l-glutamine (200 nM) and 0.1% β-mercaptoethanol (50 nM; all from Gibco).
Extracted molecule total RNA
Extraction protocol Total RNA was isolated using RNeasy mini Kit (Qiagen) as specified by the manufacturer.
Sequencing libraries were generated with the NEBNext Ultra II Directional RNA Library Prep Kit for Illumina (New England Biolabs), following the manufacturer's guidelines.
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model Illumina NextSeq 500
 
Data processing Raw FASTQ files were obtained and, after explorative quality control with FastQC (v0.11.8) and MultiQC (v1.7), we used Salmon (v0.14.1) for pseudo-alignment and quantification of the samples to the mouse transcriptome (downloaded from Ensembl, release 94). Default parameters were used.
Further analyses were performed in R. We employed the Bioconductor package tximport (v1.10.1) to summarize transcript-level estimates computed by Salmon for a gene-level analysis.
To find differentially expressed genes, we used the package DESeq2 (v1.22.2) and tested for SMARCB1 re-expression versus control conditions.
Genome_build: GRCm38
Supplementary_files_format_and_content: raw_gene_counts_matrix.txt contains tab-separated raw counts for each gene and each sample
 
Submission date Dec 06, 2021
Last update date Jul 18, 2024
Contact name Carolin Walter
E-mail(s) c_walt03@uni-muenster.de
Organization name Westfälische Wilhelms-Universität Münster
Department Medical Faculty of the WWU Münster
Lab Institute of Medical Informatics
Street address Domagkstraße 9
City Münster
ZIP/Postal code 48149
Country Germany
 
Platform ID GPL19057
Series (2)
GSE190273 SMARCB1 loss defines a novel PTCL-NOS subtype displaying an immunosuppressive TME susceptible to HDAC inhibitors [bulk RNA-seq]
GSE190276 SMARCB1 loss defines a novel PTCL-NOS subtype displaying an immunosuppressive TME susceptible to HDAC inhibitors
Relations
BioSample SAMN23703968
SRA SRX13326143

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap